The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TAS102 in combination with oxaliplatin (TASOX) for refractory metastatic colorectal cancer.
 
Sharon Li
Consulting or Advisory Role - AstraZeneca
 
Fan Ling
No Relationships to Disclose
 
Christian Misdary
No Relationships to Disclose
 
Hao Liu
No Relationships to Disclose
 
Manda DiRubbo
No Relationships to Disclose
 
Patrick Boland
Consulting or Advisory Role - BeiGene; Bristol Myers Squibb Foundation; Taiho Oncology
Research Funding - Caris Life Sciences (Inst); Compass Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)
 
Lyudmyla Berim
No Relationships to Disclose
 
Pat Gulhati
No Relationships to Disclose
 
Seth Cohen
No Relationships to Disclose
 
Jessica Taff
No Relationships to Disclose
 
Ankit Shah
No Relationships to Disclose
 
Patrick Lee
No Relationships to Disclose
 
Delia Radovich
No Relationships to Disclose
 
Stuart Leitner
Stock and Other Ownership Interests - Bridgebio; Halozyme; Novartis; Pfizer
 
Michael Scoppetuolo
No Relationships to Disclose
 
Howard Hochster
Stock and Other Ownership Interests - Compass Therapeutics
Consulting or Advisory Role - Processa Pharmaceuticals; Takeda
Expert Testimony - Natera
Travel, Accommodations, Expenses - Takeda
Other Relationship - Seagen